Animal models of congenital cytomegalovirus infection: An overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV)

Journal of Clinical Virology

Volumn 25, Issue SUPPL. 2, 2002, Pages 37-49

  Schleiss, Mark R ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

CMV vaccines; Cytomegalovirus (CMV); Guinea pig

Indexed keywords

CYTOMEGALOVIRUS VACCINE; DNA VACCINE; GLYCOPROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CHROMOSOME; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; GENE SEQUENCE; GUINEA PIG; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PREGNANCY; PRIORITY JOURNAL; PROVOCATION TEST; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0036701989     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6532(02)00100-2     Document Type: Article

References (49)

1. Adler S.P. Current prospects for immunization against cytomegaloviral disease. Inf. Agents Dis. 5:1996;29-35.
2. Alford C.A., Britt W.J. Cytomegalovirus. Roizman B., Whitley R.J., Lopez C., The Human Herpesviruses. 1993;227-255 Raven Press, New York.
3. Bratcher D.F., Bourne N., Bravo F.J., Schleiss M.R., Slaoui M., Myers M.G., Bernstein D.I. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J. Infect. Dis. 172:1995;944-950.
4. Bia F.J., Griffith B.P., Tarsio M., Hsuing G.D. Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus. J. Infect. Dis. 142:1980;732-738.
5. Bia F.J., Griffith B.P., Fong C.K.Y., Hsuing G.D. Cytomegaloviral infections in the guinea pig: experimental models for human disease. Rev. Infect. Dis. 5:1983;177-195.
6. Boppana S.B., Britt W.J. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J. Infect. Dis. 17:1995;1115-1121.
7. Borst E.M., Hahn G., Koszinowski U.H., Messerle M. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. Virology. 73:1999;8320-8329.
8. Bourne N., Schleiss M.R., Bravo F.J., Bernstein D.I. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection. J. Infect. Dis. 183:2001;59-64.
9. Brady R.C., Schleiss M.R. Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene. Arch. Virol. 141:1996;2409-2424.
10. Britt W.J., Harrison C. Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus. Virology. 201:1994;294-302.
11. Britt W.J., Mach M. Human cytomegalovirus glycoproteins. Intervirology. 39:1996;401-412.
12. Bruggeman C.A., Meijer H., Bosnian F., van Boven C.P.A. Biology of rat cytomegalovirus. Intervirology. 24:1985;1-9.
13. Choi Y.C., Hsuing G.D. Cytomegalovirus infection in guinea pigs. II. Transplacental and horizontal transmission. J. Infect. Dis. 138:1978;197-202.
14. Demmler G.J. Congenital cytomegalovirus infection. Semin. Pediatr. Neurol. 1:1994;36-42.
15. Fox D.S., Schleiss M.R. Sequence and transcriptional analysis of the guinea pig cytomegalovirus UL97 homolog. Virus Genes. 15:1997;255-264.
16. Gao M., Isom H.C. Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping. J. Virol. 52:1984;436-447.
17. Griffith B.P., McCormick S.R., Fong C.K.Y., Lavellee J.T., Lucia H.L., Goff E. The placenta as a site of cytomegalovirus infection in guinea pigs. J. Virol. 55:1985;402-409.
18. Harrison C.J., Britt W.J., Chapman N.M., Mullican J., Tracy S. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model. J. Infect. Dis. 172:1995;1212-1220.
19. Ho M. Cytomegalovirus: Biology and Infection. second ed. 1992;Plenum Publishing, New York.
20. Huber M.T., Compton T. The human cytomegalovirus UL74 gene encoded the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol. 72:1998;8191-8197.
21. Isom H.C., Yin C.Y. Guinea pig cytomegalovirus gene expression. Curr. Top. Microbiol. Immunol. 154:1990;101-121.
22. Jackson L. An intracellular protozoan parasite of the ducts of the salivary glands of the guinea pig. J. Infect. Dis. 26:1920;347-350.
23. Johnson K.P., Connor W.S. Guinea pig cytomegalovirus: transplacental transmission. J. Exp. Med. 59:1979;263-267.
24. Jones C.T., Keay S.K., Swoveland P.T. Identification of GPCMV infected cells in vitro and in vivo with a monoclonal antibody. J. Virol. Methods. 48:1994;133-144.
25. Kumar M.L., Nankervis G.A. Experimental congenital infection with cytomegalovirus: a guinea pig model. J. Infect. Dis. 138:1978;650-654.
26. Lazzarotto T., Spezzacatena P., Pradelli P., Abate D.A., Varani S., Landini M.P. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin. Lab. Diagn. Lab. Immunol. 4:1997;469-473.
27. Liu Y., Biegalke B. Characterization of a cluster of late genes of guinea pig cytomegalovirus. Virus Genes. 23:2001;247-256.
28. Lockridge K.M., Sequar G., Zhou S.S., Yue Y., Mandell C.P., Barry P.A. Pathogenesis experimental rhesus cytomegalovirus infection. J. Virol. 73:1999;9576-9583.
29. Markham F.S., Hudson N.P. Susceptibility of the guinea pig fetus to the submaxillary gland virus of guinea pigs. Am. J. Pathol. 12:1936;175-181.
30. McGregor A, Schleiss MR. Generation of guinea pig cytomegalovirus mutants via the use of a novel transposon based in vitro insertion system. Twentyfourth International Herpesvirus workshop, 1999.
31. McGregor A., Schleiss M.R. Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAG) in Escherichia coli. Mol. Gen. Metab. 72:2001;15-26.
32. McGregor A., Schleiss M.R. Recent advances in herpesvirus genetics using bacterial artificial chromosomes. Mol. Gen. Metab. 72:2001;8-14.
33. McVoy M.A., Nixon D.E., Adler S.P. Circularization and cleavage of guinea pig cytomegalovirus genomes. J. Virol. 71:1997;4209-4217.
34. Medearis D.N. Mouse cytomegalovirus infection. III. Attempts to produce intrauterine infections. Am. J. Hyg. 80:1964;113-120.
35. Messerle M., Crnkovic I., Hammerschmidt W., Ziegler H., Koszinowski U.H. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA. 94:1997;14759-14763.
36. Morello C.S., Cranmer L.D., Spector D.H. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65). J. Virol. 74:2000;3696-3708.
37. Murphy P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2:2001;116-122.
38. Nogami-Satake T., Tsutsui Y. Identification and characterization of a 50K DNA-binding protein of guinea-pig cytomegalovirus. J. Gen. Virol. 69:1988;2267-2276.
39. Paglino J.C., Brady R.C., Schleiss M.R. Molecular characterization of the guinea-pig cytomegalovirus glycoprotein L gene. Arch. Virol. 144:1999;447-462.
40. Pass R.F. Immunization strategy for prevention of congenital cytomegalovirus infection. Infect. Agents Dis. 5:1996;240-244.
41. Plotkin S.A. Vaccination against cytomegalovirus, the changeling demon. Pediatr. Infect. Dis. J. 16:1999;313-325.
42. Schleiss M.R. Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene. Virology. 202:1994;173-185.
43. Schleiss M.R. Sequence and transcriptional analysis of the guinea-pig cytomegalovirus DNA polymerase gene. J. Gen. Virol. 76:1995;1827-1833.
44. Schleiss M.R., McGregor A., Jensen N.J., Erdem G., Aktan L. Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog. Virus Genes. 19:1999;205-221.
45. Schleiss M.R., Bourne N., Jensen N.J., Bravo F., Bernstein D.I. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83. Virol. Immunol. 13:2000;155-167.
46. Schleiss M.R., Bernstein D.I., Bourne N. Anti cytomegalovirus (anti-CMV) IgG avidity following glycoprotein immunization predicts neonatal outcome in the guinea pig model of congenital CMV infection. Pediatr. Res. 49:2001;1768.
47. Staczek J. Animal cytomegaloviruses. Microbiol. Rev. 54:1990;247-265.
48. Tarantal A.F., Salamat M.S., Britt W.J., Luciw P.A., Hendrickx A.G., Barry P.A. Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macacamulatta). J. Infect. Dis. 177:1998;446-450.
49. Tsutsui Y., Yamazaki Y., Kashiwai A., Mizutani A., Furukawa T. Monoclonal antibodies to guinea-pig cytomegalovirus: an immunoeiectron microscopic study. J. Gen. Virol. 67:1986;107-118.